0001104659-21-123286.txt : 20211005 0001104659-21-123286.hdr.sgml : 20211005 20211005185144 ACCESSION NUMBER: 0001104659-21-123286 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211004 FILED AS OF DATE: 20211005 DATE AS OF CHANGE: 20211005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RUFFOLO ROBERT R CENTRAL INDEX KEY: 0001187308 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38630 FILM NUMBER: 211308221 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aridis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001614067 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320074500 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 983 UNIVERSITY AVENUE, BLDG. B CITY: LOS GATOS STATE: CA ZIP: 95032 BUSINESS PHONE: (408) 385-1742 MAIL ADDRESS: STREET 1: 983 UNIVERSITY AVENUE, BLDG. B CITY: LOS GATOS STATE: CA ZIP: 95032 4 1 tm2129291-5_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-10-04 0 0001614067 Aridis Pharmaceuticals, Inc. ARDS 0001187308 RUFFOLO ROBERT R C/O ARIDIS PHARMACEUTICALS, INC. 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032 1 0 0 0 Stock Options 3.60 2021-10-04 4 A 0 7000 0 A 2031-10-04 Common Stock 7000 49791 D The stock options vest in equal installments over 12 months, beginning on October 4, 2021. /s/ Robert Ruffolo 2021-10-05